Israeli firm receives FDA approval to begin clinical trial of chronic corneal edema treatment

The company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.

  News   Dec 15, 2025   0   3  Add to Reading List
Israeli firm receives FDA approval to begin clinical trial of chronic corneal edema treatment
ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema. (photo credit: Courtesy)
The company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow